- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
This 10-session course introduces the basics of clinical research design, including: biostatistics, design of diagnostic and predictive test studies, required/desired elements of clinical trial protocols, the regulatory aspects of clinical research conduct and oversight, Good Clinical Practice (GCP), and ethical dimensions of clinical research. Open to faculty, fellows and staff within the CTSA. A
2022 REKS Summer Series Recording: Regulatory and Ethics in Innovative Community Research The goal of this series is to highlight and discuss innovative community research, regulatory requirements, and ethical implications. July 13, 2022 "W.A.S.H: A Community-Based Participatory Research Collaboration" Featuring Dr. Roxanne Mirabal-Beltran (GUSON) Recording Link: https://www.youtube.com/watch?v
The GHUCCTS Regulatory, Ethics, Knowledge, & Support proudly presents a three-part series to address Regulatory and Ethics in Innovative Community Research Purpose: To highlight and discuss innovative community research, regulatory requirements, and ethical implications Target Audience: Clinical researchers, research teams, IRB members, students Objectives: - To understand community research and
Session recordings and slide presentations are now available from the 2021 REKS Summer Series Recording: Pathway to Decentralized Clinical Trials. The goal of this series is to discuss new developments in regulations affecting decentralized clinical trials. - Introduction to Decentralized Clinical Trials" featuring Nichelle Cobb (SMART IRB) - June 16th - Options for In-Home Clinical Trial Visits"
This module describes the unique benefits of including older adults in clinical research.
Best practices for including older adults with cognitive impairments in clinical research.
Learning Objectives: At the end of this forum you will be able to: • Clarify when genetic modification may be a responsible option for therapy • Apply ethical criteria to decide when to proceed with first-in-human trials • Recognize the role of moral intuitions in clinical research and how to move beyond them
The DC CTSA Consortium is pleased to announce the 2021 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research. This free, virtual conference will take place on Friday, April 23, 2021, and Friday, April 30, 2021, from 9:30 AM to 12:30 PM EST. Each day will feature keynote presentations and moderated panel discussions. This conference brings researchers, administrators
The DC CTSA Consortium is pleased to announce the 2021 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research. This free, virtual conference will take place on Friday, April 23, 2021, and Friday, April 30, 2021, from 9:30 AM to 12:30 PM EST. Each day will feature keynote presentations and moderated panel discussions. This conference brings researchers, administrators
The CCTS Bioethics Forum brings together researchers, bioethicists, students, community members, front-line research staff, and clinical staff to discuss ethical issues in research. This year's event will focus on the topic of "Equity and Trust for COVID-19 Testing, Treatment, and Vaccination: Where Do We Go from Here?"
Sexual and gender minority (SGM) is an umbrella term that encompasses lesbian, gay, bisexual, and transgender populations as well as those whose sexual orientation, gender identity and expressions, or reproductive development varies from traditional, societal, cultural, or physiologic norms. Research with SGM populations is lacking, but is desperately needed to help understand and improve their
This annual meeting brings researchers, administrators, and clinical professionals from throughout the Clinical and Translational Sciences Awards (CTSA) region together for collaborative discussion and response to regulatory revisions and identified clinical research priorities within the current landscape of clinical trials. The focus for this meeting was “COVID-19: the Virus, Preparedness in the